通过使用基因组数据计算遗传性癌症中检测到的致病变体和等位基因频率来生成数据库:一项国家研究
Manal Salah Babiker Ali1, Polat Olgun2, Ömer Diker2
1Department of Medical Genetics, Faculty of Medicine, Near East University, Nicosia 99138, Cyprus.
Global medical genetics
|June 18, 2025
概括
基因查确定了遗传性癌症基因中的致病变体,其中BRCA1和BRCA2突变是最常见的. 这些发现强调了家族历史.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 遗传性癌症是由遗传的基因变异引起的,增加了癌症风险.
- 像BRCA1/2这样的基因显著影响了对家族性癌症的易感性.
- 了解这些遗传倾向对于有效的癌症管理至关重要.
研究的目的:
- 分析遗传性癌症相关基因的遗传结果.
- 识别致病变体及其频率,以改善风险评估.
- 加强遗传咨询和针对性查在遗传性癌症管理.
主要方法:
- 一组298名患者接受了综合遗传性癌症小组测试.
- 该小组分析了52个与遗传癌症倾向相关的基因.
- 桑格测序验证了所有治疗相关的发现.
主要成果:
- 21.48%的个体对遗传性癌症相关的致病变体呈阳性.
- 女性的阳性率更高 (89.06%),乳腺癌最常见 (246例).
- 检测到的基因包括BRCA1,BRCA2,ATM,MSH2,MUTYH和PALB2,其中一个特定的BRCA1变异发生在高频率.
结论:
- 在遗传性癌症基因中发现了关键的致病变体,特别是BRCA1和BRCA2.
- 家庭病史和遗传性癌症风险之间的强烈联系得到了加强.
- 综合基因查和个性化咨询对于遗传性癌症风险评估和早期检测至关重要.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.3K
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
11.1K
相关概念视频
Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K
Cancers Originate from Somatic Mutations in a Single Cell
13.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.1K
